Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors
Clinical trial NCT05729399 · TERMINATED
Trial details
- NCT number
- NCT05729399
- Sponsor
- Grit Biotechnology
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2025-12-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.